ALL-CAUSE MORTALITY IN A SYSTEMIC LUPUS ERYTHEMATOSUS COHORT

被引:0
|
作者
Petri, M. A. [1 ]
Levy, J. [2 ]
Sbarigia, U. [3 ]
Goldman, D. [4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Hlth Policy & Management, Baltimore, MD USA
[3] Janssen Pharmaceut NV, Global Serv, Beerse, Belgium
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
Gender/diversity issues; Real-world evidence; Systemic lupus; erythematosus;
D O I
10.1136/annrheumdis-2023-eular.2726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1500
引用
收藏
页码:1107 / 1108
页数:2
相关论文
共 50 条
  • [21] Undertreatment of Disease Activity in Systemic Lupus Erythematosus Patients with Endstage Renal Failure Is Associated with Increased All-cause Mortality
    Broder, Anna
    Khattri, Saakshi
    Patel, Ruchika
    Putterman, Chaim
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2382 - 2389
  • [22] ALL-CAUSE HOSPITALIZATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS FROM A NORTHERN ITALIAN REFERRAL CENTRE
    Bortoluzzi, A.
    Padovan, M.
    De Stefani, E.
    Govoni, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 973 - 973
  • [23] ALL-CAUSE AND SPECIFIED CAUSES OF MORTALITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS
    Souto, A.
    Castelo, A.
    Maneiro, J. R.
    Cervantes, E.
    Mera, A.
    Gomez-Reino, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 127 - 128
  • [24] Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus
    Amy H Kao
    Christine A. McBurney
    Abdus Sattar
    Apinya Lertratanakul
    Nicole L. Wilson
    Sarah Rutman
    Barbara Paul
    Jeannine S Navratil
    Andrea Scioscia
    Joseph M. Ahearn
    Susan Manzi
    Translational Stroke Research, 2014, 5 : 510 - 518
  • [25] Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan
    Lin, Wei-Hung
    Guo, Chao-Yu
    Wang, Wei-Ming
    Yang, Deng-Chi
    Kuo, Te-Hui
    Liu, Ming-Fei
    Wang, Ming-Cheng
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (06) : 747 - 753
  • [26] MORTALITY IN SYSTEMIC LUPUS ERYTHEMATOSUS IN A ARGENTINIAN COHORT
    Juarez, V.
    Aciar, M.
    Cucchiaro, N.
    Rojas Tessel, R.
    Picco, E.
    Buschiazzo, E.
    Lencina, M. V.
    Aciar, M. D. L. A.
    Artes Rocha, I.
    Crespo Espindola, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1083 - 1083
  • [27] All-Cause Mortality, Hospitalization, and Systemic Lupus Erythematosus (SLE) Related Complications in 2011-2015 Medicare Beneficiaries with SLE
    Li, Suying
    Peng, Yi
    Gong, Tingting
    Nieman, Kimberly M.
    Gilbertson, David I.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] Comparative Rates of Serious Infections and All-Cause Mortality Among Systemic Lupus Erythematosus Patients Receiving Mycophenolate Mofetil Versus Azathioprine
    Feldman, Candace H.
    Marty, Francisco M.
    Winkelmayer, Wolfgang C.
    Guan, Hongshu
    Franklin, Jessica M.
    Solomon, Daniel H.
    Kim, Seoyoung C.
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [29] Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry
    Mendoza-Pinto, Claudia
    Etchegaray-Morales, Ivet
    Garcia-Carrasco, Mario
    Munguia-Realpozo, Pamela
    Mendez-Martinez, Socorro
    David Osorio-Pena, Angel
    Jose Montiel-Jarquin, Alvaro
    LUPUS, 2022, 31 (03) : 382 - 391
  • [30] MORTALITY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: A STUDY OF THE BATH LUPUS COHORT
    Ellis, J.
    Korendowych, E.
    Skeoch, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1094 - 1095